Page last updated: 2024-10-27

flurbiprofen and Experimental Leukemia

flurbiprofen has been researched along with Experimental Leukemia in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research Excerpts

ExcerptRelevanceReference
"Animals bearing metastatic fibrosarcomas were treated with cyclophosphamide (CY) alone or in combination with flurbiprofen (FP), an inhibitor of prostaglandin synthesis."3.66Failure of short-term treatment with flurbiprofen to enhance the therapeutic effect of cyclophosphamide against rodent sarcomas and a leukaemia. ( Alexander, P; Eccles, SA; Heckford, SE; Powles, TJ, 1982)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heckford, SE1
Eccles, SA1
Powles, TJ1
Alexander, P1

Other Studies

1 other study available for flurbiprofen and Experimental Leukemia

ArticleYear
Failure of short-term treatment with flurbiprofen to enhance the therapeutic effect of cyclophosphamide against rodent sarcomas and a leukaemia.
    British journal of cancer, 1982, Volume: 46, Issue:1

    Topics: Animals; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Female; Fibrosarcoma; Flurbipr

1982